CP
Compass Pathways
OrganizationHeard in 3 episodes across 3 shows since Sep 2026
A biotechnology company focused on developing psilocybin therapy and innovative mental health treatments for patients.
Episodes
3
across 3 shows
First heard
Sep 2026
Expert statements
1
1 positive
Episodes per month
Public PodLume episodes featuring it, over the last year.
3
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 3 |
| Oct 2026 | 0 |
What experts have said about Compass Pathways
1 statement · 1 positive
Compass Pathways leads the race for first psychedelic treatment approval.
“Compass is actually in the lead for potentially getting the first psychedelic treatment approved”
Open the episode · Chime, Boston Scientific Falls, Compass Pathways RisesListen at 3:03
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
3 episodes featuring Compass Pathways, newest first
- Sep 28, 2026
Pollan asks whether the brain creates consciousnessHuberman Lab EssentialsSep 28, 2026 - Sep 18, 2026
Australia’s psychedelic breakthrough offers advocates a regulatory playbookThe Tim Ferriss ShowSep 18, 2026 - Sep 8, 2026
Chime bets on bank ownership as cyberattacks hit healthcareStock MoversSep 8, 2026